URAC is proud to congratulate AIS Healthcare (accredited as Bond Pharmacy) for receiving our Medicare Home Infusion Therapy Supplier (MHITS) Accreditation, showcasing their drive to deliver specialized, in-home infusion services of the highest quality. AIS Healthcare is the first organization to secure this specific accreditation from URAC.
URAC is the independent leader in promoting health care quality through leadership, accreditation, measurement and innovation. The new MHITS accreditation from URAC focuses on the key role that pharmacists play in providing infusion therapy services and recognizes pharmacies that excel in this area. Additionally, home infusion therapy suppliers must be accredited by January 1, 2021 to qualify for bundled payment reimbursement from Medicare and URAC is approved by CMS to offer that accreditation.
“Attaining MHITS accreditation is not easy, nor should it be,” said URAC President and CEO Shawn Griffin, M.D. “When an organization like AIS Healthcare achieves this distinction, it says they are quality-driven and posting results at the highest levels. We’re pleased to recognize their hard work and success.”
By earning a MHITS accreditation at Bond Pharmacy, its specialty compounding pharmacy in Ridgeland, Mississippi, AIS Healthcare has demonstrated its commitment to going above and beyond to support patients and empower their providers. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, the entire company goes beyond the expected in everything it does.
“Throughout AIS Healthcare, we’re focused on doing more of what matters throughout the care continuum,” said Pam Carter, Chief Nursing Officer at AIS Healthcare. “This recognition from URAC shows how doing more to advance quality truly does result in meaningful improvements for patients and providers.”
AIS Healthcare has also earned Specialty Pharmacy and Health Call Center accreditations from URAC.